Added to Cart
More deals you may like
Handbook of Incretin-Based Therapies in Type 2 Diabetes
This product is shipped via the most economical route and is estimated to be delivered within 2-3 weeks of your order leaving the warehouse.
This concise handbook provides an overview of incretin-based therapies and guidance for incorporating them into the treatment of type 2 diabetes. Chapters include landmark clinical trials and international treatment guidelines in order to update readers with all major advances in the field. An ideal resource for medical professionals that treat patients with type 2 diabetes in hospital and clinical settings.
Stephen Gough is Professor of Diabetes at the University of
Oxford and Consultant Physician at the Oxford University Hospitals NHS Trust.
Professor Gough graduated in medicine from Leeds University Medical School,
where he was later awarded a higher degree Doctorate in Medicine, which focused
on cardiac dysfunction and abnormalities in coagulation and fibrinolysis
present at the time of diagnosis of type 2 diabetes. He is currently based at
the Oxford Centre for Diabetes, Endocrinology and Metabolism, where he is a
practicing clinician in diabetes. His research interests and ongoing research
studies include translational aspects of diabetes, with a focus on the
physiology of islet cell and whole organ pancreas transplantation, incretin
biology, and incretin therapies in diabetes. Professor Gough has previously had
a strong interest in the genetic susceptibility to autoimmunity and this work
has been extended into his work on pancreas transplantation. He has published
his research extensively in peer-reviewed journals and has contributed to many
national and international conferences and books on diabetes. In recent years,
Professor Gough has helped develop translation research in diabetes in Oxford
through a number of local and national initiatives, including the Oxford
Biomedical Research Centre, and he is Clinical Lead in Diabetes for the Oxford
Academic Health Science Network and the Oxford Local Clinical Research Network.
Since editing this book, Professor Gough has taken up the
position of Senior Principal Clinical Scientist with Novo Nordisk. He continues
as Visiting Professor of Diabetes at the University of Oxford and Honorary
Consultant with the Oxford University Hospitals NHS Trust.